DigestRedComo funciona
Red
/
Empresas
En
No verificado

Enanta Pharmaceuticals, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosSaludVIH, SIDA y enfermedades autoinmunes

38 Comunicados de prensa

Ver todos los comunicados de prensa
03/03/2026
Web y redes sociales
Eventos
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Enanta Pharmaceuticals to Present at The Citizens Life Sciences Conference
Fuente
Enanta Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
10/02/2026
Salud
VIH, SIDA y enfermedades autoinmunes
Biotecnología
Sanidad
Medicina - Varios
Farmacéutica
Eventos
Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for the Treatment of Type 2 Immune Diseases, at the 2026 AAAAI Annual Meeting
Fuente
Enanta Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
09/02/2026
Eventos
Mercado de valores
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Medicina - Varios
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025
Fuente
Enanta Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
08/01/2026
Ciencia
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
VIH, SIDA y enfermedades autoinmunes
Medicina - Varios
Web y redes sociales
Eventos
Industria
Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook
Fuente
Enanta Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
05/01/2026
Ciencia
VIH, SIDA y enfermedades autoinmunes
Medicina - Varios
Sanidad
Biotecnología
Farmacéutica
Salud
Web y redes sociales
Eventos
Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
Fuente
Enanta Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
17/11/2025
Mercado de valores
Salud
VIH, SIDA y enfermedades autoinmunes
Biotecnología
Medicina - Varios
Farmacéutica
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2025
Fuente
Enanta Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
04/11/2025
Eventos
Web y redes sociales
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Enanta Pharmaceuticals to Participate in Upcoming Investor Conferences
Fuente
Enanta Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
20/10/2025
Salud
VIH, SIDA y enfermedades autoinmunes
Biotecnología
Sanidad
Medicina - Varios
Farmacéutica
Eventos
Enanta Pharmaceuticals Presents New Data for Zelicapavir, its N-Protein Inhibitor, and EDP-323, its L-Protein Inhibitor, Both in Development for the Treatment of Respiratory Syncytial Virus (RSV) at IDWeek™ 2025
Fuente
Enanta Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
07/10/2025
Ciencia
Biotecnología
Farmacéutica
Salud
VIH, SIDA y enfermedades autoinmunes
Sanidad
Eventos
Industria
Enanta Pharmaceuticals to Present Data for Zelicapavir and EDP-323, Two Candidates in Development for the Treatment of Respiratory Syncytial Virus (RSV) at IDWeek™ 2025
Fuente
Enanta Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0
02/10/2025
Ciencia
Biotecnología
Farmacéutica
Finanzas
Salud
Asociaciones/Profesionales
Medicina - Varios
Enanta Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Fuente
Enanta Pharmaceuticals, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0